Research of the common tuberculosis (TB) drug pyrazinamide, which is used in combination with other medications to treat the disease in a six-month regimen, “has now revealed that the drug does kill the latent form of the microbe, which does not cause observable symptoms,” VOA News reports.
As countries increase the use of the GeneXpert test, a two-hour molecular TB test released in 2010, “enabl[ing] them to diagnose more patients with drug-resistant tuberculosis (DR-TB), a worldwide shortage of the drugs to treat these patients is likely, Medecins Sans Frontieres (MSF) warns,” according to PlusNews.
Bayer Healthcare announced on MondayÂ it “has agreed to support the World Health Organization (WHO) and the Stop TB Partnership in the fight against multidrug-resistant tuberculosis (MDR-TB) by making 620,000 tablets of the antibiotic moxifloxacin available to WHO,” according to a Bayer press release.Â The WHO will provide the antibiotics to China’s…
A guest post in PLoS Medicine’s “Speaking of Medicine” blog, written by tuberculosis (TB) researchers Madhukar Pai of McGill University, David Dowdy of the Johns Hopkins Bloomberg School of Public Health, and Karen Steingart of the University of Washington School of Public Health, examines the medical, public health and economic…
CDC Director Thomas Frieden, who currently is visiting India and who previously worked with the Indian government assisting in tuberculosis (TB) control, praised the country’s “progress in controlling tuberculosis and tobacco use” on Monday during a speech to health practitioners and policymakers, according to the Wall Street Journal’s “India Real Time” blog. Frieden also noted “India’s strides in the past decade on â€¦ polio control and HIV/AIDS prevention,” the blog reports.
U.S. Delegation in South Africa To Renew Bilateral Relationship, Create Sustainable Partnerships in Health
This post on the Center for Strategic and International Studies (CSIS)’s Commission on Smart Global Health Policy blog examines tuberculosis (TB) in South Africa, “which has the highest tuberculosis infection rate per population and accounts for 5 percentÂ of the global TB burden.” The post isÂ part of a seriesÂ to be posted…
The June/July issue of USAID’s Frontlines focuses on climate change, including an article on how Kenyan farmers are adapting to environmental changes. The issue also includes articles on how the search for an HIV vaccine has boosted African research and on the introduction of the GeneXpert tuberculosis test in Central…
The WHO “called on Wednesday for an immediate halt to the use of blood tests to detect active tuberculosis [TB], saying they were faulty and leave millions of people at risk,” Reuters reports.
The WHO on Sunday said it will release a guidance later this week on widely used blood tests for tuberculosis (TB), warning “against using such tests for the infectious lung disease that affects some 14 million people worldwide” because they can produce incorrect results, the Associated Press/Washington Post reports.
A report (.pdf) released recently and compiled by the Treatment Action Group, Medecins Sans Frontieres and Partners In Health says that international efforts aimed at scaling up treatment of multi-drug resistant tuberculosis (MDR-TB) have been slow due to weak government action, low funding and a “sluggish response by international support mechanisms,” BMJ News reports.